Bioconjugation Market Growth, Size, Trends Analysis - By Product & Services, By Technique, By Biomolecule Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Bioconjugation Market Introduction and Overview

According to SPER Market Research, 'Global Bioconjugation Market Size- By Product & Services, By Technique, By Biomolecule Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Bioconjugation Market is predicted to reach 14.81 billion by 2034 with a CAGR of 9.73%.

Bioconjugation refers to the chemical or biological method of attaching two molecules, typically a biomolecule like an antibody, protein, or peptide, to another molecule such as a drug, fluorophore, or polymer, creating a functional unit. This process is crucial for targeted drug delivery, diagnostics, and molecular imaging, offering enhanced targeting and improved efficacy. Examples of bioconjugation include antibody-drug conjugates (ADCs), biosensors, and molecular imaging agents.

RESTRAINTS: A significant challenge facing the global bioconjugation market is the high expenses and complexities associated with the bioconjugation processes. These operations frequently necessitate sophisticated technologies, specialized reagents, and meticulous control over reaction conditions, which substantially elevate production costs. Furthermore, the requirement for site-specific conjugation to maintain biological activity adds to the intricacy.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product & Services, By Technique, By Biomolecule Type, By Application, By End User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Thermo Fisher Scientific, Danaher, Lonza Group, Merck KGaA (MilliporeSigma), Sartorius AG, Abbvie, Inc, Agilent Technologies, Inc, Bio-rad Laboratories, Inc, Catalent, Inc, BD.

Global Bioconjugation Market Segmentation:

By Product & Services: Based on the Product & Services, Global Bioconjugation Market is segmented as; Consumables, Instruments, Services.

By Biomolecule Type: Based on the Biomolecule Type, Global Bioconjugation Market is segmented as; Antibodies, Proteins, Peptides, Oligonucleotides, Other Biomolecules.

By Technique: Based on the Technique, Global Bioconjugation Market is segmented as; Chemical Conjugation, Enzyme-Mediated Conjugation, Click Chemistry, Photoreactive Crosslinking, Other Techniques.

By Application: Based on the Application, Global Bioconjugation Market is segmented as; Therapeutics, Research & Development, Diagnostics.

By End User: Based on End User, Global Bioconjugation Market is segmented as; Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, Hospitals, Clinical & Diagnostic Laboratories.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: BIOT2506

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Bioconjugation Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bioconjugation Market

7. Global Bioconjugation Market, By Product & Services (USD Million) 2021-2034

7.1. Consumables
- 7.1.1. Reagents & Kits
- 7.1.2. Labels
7.2. Instruments
- 7.2.1. Chromatography Systems
- 7.2.2. Spectroscopy Instruments
- 7.2.3. Mass Spectrometers
- 7.2.4. Flow Cytometers
- 7.2.5. Electrophoresis Equipment
- 7.2.6. Filtration Systems
- 7.2.7. Mixers & Shakers
- 7.2.8. Incubators
- 7.2.9. Other Instruments
7.3. Service
- 7.3.1. Custom Synthesis & Conjugation Services
- 7.3.2. Analytical & Characterization Services
- 7.3.3. Scale-up & Manufacturing Services
- 7.3.4. Other Services

8. Global Bioconjugation Market, By Biomolecule Type (USD Million) 2021-2034

8.1. Antibodies
8.2. Proteins
8.3. Peptides
8.4. Oligonucleotides
8.5. Other Biomolecules

9. Global Bioconjugation Market, By Technique (USD Million) 2021-2034

9.1. Chemical Conjugation
9.2. Enzyme-Mediated Conjugation
9.3. Click Chemistry
9.4. Photoreactive Crosslinking
9.5. Other Technique

10. Global Bioconjugation Market, By Application (USD Million) 2021-2034

10.1. Therapeutics
- 10.1.1. Antibody-drug Conjugates
- 10.1.2. Protein-drug Conjugates
- 10.1.3. Peptide-drug Conjugates
- 10.1.4. Other Therapeutic Applications
10.2. Research & Development
10.3. Diagnostics

11. Global Bioconjugation Market, By End User (USD Million) 2021-2034

11.1. Pharmaceutical & Biotechnology Companies
11.2. CROs & CMOs
11.3. Academic & Research Institutes
11.4. Hospitals, Clinical & Diagnostic Laboratories

12. Global Bioconjugation Market, (USD Million) 2021-2034

12.1. Global Bioconjugation Market Size and Market Share

13. Global Bioconjugation Market, By Region, (USD Million) 2021-2034

13.1. Asia-Pacific
- 13.1.1. Australia
- 13.1.2. China
- 13.1.3. India
- 13.1.4. Japan
- 13.1.5. South Korea
- 13.1.6. Rest of Asia-Pacific
13.2. Europe
- 13.2.1. France
- 13.2.2. Germany
- 13.2.3. Italy
- 13.2.4. Spain
- 13.2.5. United Kingdom
- 13.2.6. Rest of Europe
13.3. Middle East and Africa
- 13.3.1. Kingdom of Saudi Arabia
- 13.3.2. United Arab Emirates
- 13.3.3. Qatar
- 13.3.4. South Africa
- 13.3.5. Egypt
- 13.3.6. Morocco
- 13.3.7. Nigeria
- 13.3.8. Rest of Middle-East and Africa
13.4. North America
- 13.4.1. Canada
- 13.4.2. Mexico
- 13.4.3. United States
13.5. Latin America
- 13.5.1. Argentina
- 13.5.2. Brazil
- 13.5.3. Rest of Latin America

14. Company Profile

14.1. Thermo Fisher Scientific
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
14.2. Danaher
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
14.3. Lonza Group
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
14.4. Merck KGaA (MilliporeSigma)
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
14.5. Sartorius AG
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
14.6. Abbvie, Inc
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
14.7. Agilent Technologies, Inc
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
14.8. Bio-rad Laboratories, Inc
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
14.9. Catalent, Inc
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
14.10. BD
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3 Product summary
- 15.10.4. Recent developments
14.11. Others